Table 2 The baseline laboratory test results of all 67 study patients with COVID-19
Assay (normal range) | All patients (n = 67 or specified) | Common patients (n = 64 or specified) | Severe patients (n = 3 or specified) |
|---|---|---|---|
ALT (9–50 U/L) | 31.0 ± 31.6 | 30.3 ± 32.0 | 46.0 ± 17.0 |
AST (15–40 U/L) | 29.0 ± 18.5 | 28.3 ± 18.6 | 45.0 ± 6.2 |
ALP (45–125 U/L) | 79.8 ± 43.1 | 79.8 ± 44.0 | 79.3 ± 20.1 |
GGT (10–60 U/L) | 37.3 ± 44.8 | 35.0 ± 42.3 | 86.7 ± 77.9 |
ALB (40–55 g/L) | 41.5 ± 5.2 | 41.5 ± 5.3 | 40.8 ± 1.7 |
TP (60–85 g/L) | 69.6 ± 5.8 | 69.6 ± 5.8 | 71.7 ± 5.2 |
GLO (20–40 g/L) | 28.6 ± 3.9 | 28.5 ± 3.9 | 30.9 ± 3.7 |
A/G (1.2–2.4) | 1.5 ± 0.2 | 1.5 ± 0.2 | 1.3 ± 0.1 |
TBIL (0–23 μmol/L) | 9.1 ± 4.6 | 9.1 ± 4.6 | 9.8 ± 4.2 |
IBIL (1.2–16 μmol/L) | 5.3 ± 3.2 | 5.3 ± 3.2 | 5.5 ± 3.0 |
DBIL (0–8 μmol/L) | 3.8 ± 1.6 | 3.8 ± 1.6 | 4.3 ± 1.2 |
TBA (0–10 μmol/L) | 6.8 ± 14.5 | 7.0 ± 14.8 | 3.5 ± 2.1 |
PALB (0.2–0.43 g/L) | 0.2 ± 0.1 | 0.2 ± 0.1 | 0.1 ± 0.04 |
CHE (4.62–11.5 KU/L) | 8.8 ± 2.0 | 8.8 ± 2.0 | 10.3 ± 1.3 |
GLU (3.9–6.1 mmol/L) | 6.1 ± 1.3 | 6.1 ± 1.3 | 6.1 ± 0.7 |
BUN (3.6–9.5 mmol/L) | 3.9 ± 1.0 | 4.0 ± 1.0 | 3.6 ± 0.8 |
CREA (μmol /L) | 65.1 ± 11.0 | 65.3 ± 11.2 | 62.3 ± 4.9 |
K+ (3.5–5.3 mmol/L) | 3.7 ± 0.4 | 3.8 ± 0.4 | 3.7 ± 0.2 |
Na+ (137-147 mmol/L) | 138.9 ± 2.5 | 139.0 ± 2.4 | 136.6 ± 3.4 |
CK (50–310 U/L) | 100.9 ± 115.4 | 88.8 ± 69.9 | 359.7 ± 424.5 |
CK-MB (0–24 U/L) | 23.2 ± 19.9 | 22.6 ± 20.1 | 35.7 ± 13.3 |
LDH (120–250 U/L) | 223.0 ± 68.4 | 215.6 ± 59.3 | 380.3 ± 68.5 |
TG (0.56–1.7 mmol/L) | 1.3 ± 0.7 | 1.3 ± 0.7 | 1.46 ± 0.3 |
CHO (3.1–5.2 mmol/L) | 4.2 ± 0.9 | 4.2 ± 0.9 | 4.5 ± 0.3 |
HDL-C (1.03–3.0 mmol/L) | 1.0 ± 0.3 | 1.0 ± 0.3 | 1.0 ± 0.2 |
LDL-C (2.1–3.12 mmol/L) | 2.7 ± 0.7 | 2.7 ± 0.8 | 3.1 ± 0.3 |
CRP (0-6 mg/L) | 12.1 ± 19.3↑ | 9.8 ± 13.8↑ | 61.3 ± 50.2↑ |
PT (10–13.5 s) | 11.0 ± 0.7 | 11.0 ± 0.7 | 11.0 ± 0.1 |
PTA (70–140%) | 100.4 ± 10.0 | 100.4 ± 10.3 | 99.4 ± 1.4 |
INR (0.85–1.15) | 1.0 ± 0.1 | 1.0 ± 0.1 | 1.0 ± 0.006 |
aPTT (22–36 s) | 31.8 ± 4.4 | 31.5 ± 4.1 | 37.9 ± 8.5 |
FIB (2.0–4.0 g/L) | 3.8 ± 2.6 | 3.8 ± 2.6 | 5.0 ± 0.7 |
CT (14–21 s) | 16.9 ± 0.7 | 16.9 ± 0.7 | 16.6 ± 0.6 |
D-Dimer (0–0.5μg/mL) | 0.3 ± 0.3 | 0.3 ± 0.4 | 0.3 ± 0.1 |
WBC (3.5–9.5*10^9/L) | 4.7 ± 1.8 | 4.7 ± 1.8 | 4.4 ± 0.9 |
Lymphocyte (1.1–3.2*10^9/L) | 1.4 ± 0.6 | 1.5 ± 0.6 | 0.9 ± 0.3 |
Neutrophils (1.8–6.3*10^9/L) | 2.8 ± 1.4 | 2.7 ± 1.4 | 3.3 ± 0.8 |
RBC (4.3–5.8*10^12/L) | 4.5 ± 0.5 | 4.5 ± 0.5 | 4.9 ± 0.5 |
Hgb (130–175 g/L) | 135.1 ± 16.9 | 134.7 ± 17.0 | 145.0 ± 12.8 |
HCT (40–50%) | 39.4 ± 4.2 | 39.3 ± 4.2 | 42.7 ± 2.6 |
Platelets (125–350*10^9/L) | 194.8 ± 71.9 | 197.4 ± 72.1 | 139.7 ± 46.5 |
Blood PH (7.350–7.450) | 7.4 ± 0.03(n = 62) | 7.4 ± 0.03 (n = 59) | 7.4 ± 0.008 |
pO2 (80–100 mmHg) | 105.8 ± 27.8(n = 62) | 106.6 ± 27.6(n = 59) ↑ | 89.8 ± 33.5 |
pCO2 (35–45 mmHg) | 39.2 ± 3.4(n = 62) | 39.3 ± 3.4(n = 59) | 36.4 ± 1.2 |
sO2 (91.9–99.0%) | 97.4 ± 1.8(n = 62) | 97.5 ± 1.6(n = 59) | 94.8 ± 3.7 |
HCO3−(21-27 mmol/L) | 24.5 ± 2.0(n = 62) | 24.5 ± 2.1 (n = 59) | 23.7 ± 0.4 |
AG (8–16 mmol/L) | 10.9 ± 2.2(n = 62) | 11.0 ± 2.2 (n = 59) | 10.5 ± 2.2 |
Lac (0.5–1.7 mmol/L) | 1.7 ± 0.6(n = 62) | 1.7 ± 0.6(n = 59) | 1.7 ± 0.6 |
PCT (< 0.5 ng/ml) | 0.2 ± 0.08 (n = 56) | 0.2 ± 0.08(n = 54) | 0.24 ± 0 (n = 2) |
BNP (0–100.0 pg/ml) | 12.2 ± 6.4 (n = 59) | 12.3 ± 6.5 (n = 56) | 10.0 ± 0 |
cTnI (0.00–0.08 ng/ml) | 0.004 ± 0.007 (n = 60) | 0.004 ± 0.008 (n = 57) | 0.003 ± 0.002 |
CD3 (690–1760/ul) | 1088.3 ± 451.8 (n = 46) | 1101.2 ± 448.3 (n = 45) | 509 (n = 1) |
CD4 (410–884/ul) | 621.2 ± 287.1 (n = 46) | 627.0 ± 287.6 (n = 45) | 357 (n = 1) |
CD8 (190–658/ul) | 384.9 ± 182.1(n = 46) | 390.4 ± 180.2 (n = 45) | 135 (n = 1) |
NK cells (90–536/ul) | 339.4 ± 175.5(n = 46) | 339.8 ± 177.5 (n = 45) | 324(n = 1) |
CD19 (90–323/ul) | 211.2 ± 187.9(n = 46) | 212.6 ± 189.8 (n = 45) | 145(n = 1) |